Shen-Ling-Bai-Zhu-San for ulcerative colitis

摘要: Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) at the colonic mucosa and submucosa. Shen-Ling-Bai-Zhu-San (SLBZS) one of most common formulations traditional Chinese medicine (TCM) for treatment UC. However, its effects safety remain uncertain. This protocol described systematic review to investigate beneficial SLBZS Methods We will systematically search eligible studies in PubMed, Cochrane library, Embase, Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Wanfang Data (WAN FANG) until August 2018. The primary outcomes are induction remission maintenance remission. summary results be pooled using random-effects model or fixed-effects according heterogeneity included studies. Results submitted peer-reviewed journal publication. Conclusion conclusion our provide evidence judge whether an effective intervention patient with Prospero registration number PROSPERO CRD 42018100477.